Cargando…

Erratum to: New Directions for Rabbit Antithymocyte Globulin (Thymoglobulin(®)) in Solid Organ Transplants, Stem Cell Transplants and Autoimmunity

Detalles Bibliográficos
Autores principales:	Mohty, Mohamad, Bacigalupo, Andrea, Saliba, Faouzi, Zuckermann, Andreas, Morelon, Emmanuel, Lebranchu, Yvon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2014
Materias:	Erratum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4643552/ http://dx.doi.org/10.1007/s40265-014-0334-1

Ejemplares similares

New Directions for Rabbit Antithymocyte Globulin (Thymoglobulin(®)) in Solid Organ Transplants, Stem Cell Transplants and Autoimmunity
por: Mohty, Mohamad, et al.
Publicado: (2014)

Does Rabbit Antithymocyte Globulin (Thymoglobuline®) Have a Role in Avoiding Delayed Graft Function in the Modern Era of Kidney Transplantation?
por: Guirado, Lluís
Publicado: (2018)

Risk factors for impaired CD4(+) T-cell reconstitution following rabbit antithymocyte globulin treatment in kidney transplantation
por: Longuet, Hélène, et al.
Publicado: (2014)

A Review of Induction with Rabbit Antithymocyte Globulin in Pediatric Heart Transplant Recipients
por: Schweiger, Martin, et al.
Publicado: (2018)

Tailored Rabbit Antithymocyte Globulin Induction Dosing for Kidney Transplantation
por: Singh, Namita, et al.
Publicado: (2018)

Retrospective Evaluation of Rabbit Antithymocyte Globulin Induction in Heart Transplant Patients
por: Lee, Grace Pui-Yun, et al.
Publicado: (2022)

Induction with Rabbit Antithymocyte Globulin following Orthotopic Liver Transplantation for Hepatitis C
por: Saidi, R. F., et al.
Publicado: (2011)

Rabbit Antithymocyte Globulin Induction in Heart Transplant Recipients at High Risk for Rejection
por: Kitto, Brent, et al.
Publicado: (2021)

Timing of rabbit antithymocyte globulin induction therapy in kidney transplantation: an observational cohort study
por: Harrison, Jennifer J, et al.
Publicado: (2014)

Rabbit Antithymocyte Globulin Causes Blastomyces and Histoplasma Antigenemia
por: Kaur, Amrit, et al.
Publicado: (2019)

Antithymocyte globulin-induced refractory hypotension in renal transplantation recipient
por: Rafat, Shamim, et al.
Publicado: (2017)

Tecelac as antithymocyte globulin in conditioning for childhood allogeneic stem cell transplantation
por: Zimmermann, SY, et al.
Publicado: (2002)

What Role Is There for Antithymocyte Globulin in Allogeneic Nonmyeloablative Canine Hematopoietic Cell Transplantation?
por: Diaconescu, Razvan, et al.
Publicado: (2005)

Thymoglobulin induction in heart transplantation: patient selection and implications for maintenance immunosuppression
por: Zuckermann, Andreas, et al.
Publicado: (2015)

Erratum to: Long-term safety and efficacy of antithymocyte globulin induction: use of integrated national registry data to achieve ten-year follow-up of 10–10 Study participants
por: Lentine, Krista L., et al.
Publicado: (2015)

Relationship between Post-kidney Transplantation Antithymocyte Globulin Therapy and Wound Healing Complications
por: Pourmand, G. R., et al.
Publicado: (2012)

Meta-analysis of the actions of antithymocyte globulin in patients undergoing allogeneic hematopoietic cell transplantation
por: Yuan, Jiaojiao, et al.
Publicado: (2017)

Effect of antithymocyte globulin source on outcomes of bone marrow transplantation for severe aplastic anemia
por: Kekre, Natasha, et al.
Publicado: (2017)

Antithymocyte globulin exposure in CD34(+) T-cell–depleted allogeneic hematopoietic cell transplantation
por: Lakkaraja, Madhavi, et al.
Publicado: (2022)

Antithymocyte Globulin: Indiscriminate Use and Complications
por: Khan, Taqi, et al.
Publicado: (2019)

Incidence, Risk Factors, and Outcomes of Kidney Transplant Recipients Treated With Both Basiliximab and Antithymocyte Globulin
por: Jeong, Rachel, et al.
Publicado: (2020)

Reactivation of Hemophagocytic Lymphohistiocytosis Triggered by Antithymocyte Globulin
por: Matsuda, Kensuke, et al.
Publicado: (2017)

The Benefit of Sirolimus Maintenance Immunosuppression and Rabbit Antithymocyte Globulin Induction in Liver Transplant Recipients That Develop Acute Kidney Injury in the Early Postoperative Period
por: Duhart, Benjamin T., et al.
Publicado: (2015)

Reassessing Rabbit Antithymocyte Globulin Induction in Kidney Transplantation (RETHINK): An Analysis of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) Registry
por: Ashoor, Isa F., et al.
Publicado: (2020)

Poor Patient and Graft Outcome After Induction Treatment by Antithymocyte Globulin in Recipients of a Kidney Graft After Nonrenal Organ Transplantation
por: Mai, Hoa Le, et al.
Publicado: (2018)

Antithymocyte Globulin Antibody Titer Congruent With Kidney Transplantation: Analysis of Incidence, Outcomes, Cost, and Alternative Targets
por: Lattimore, Sherene, et al.
Publicado: (2019)

Role of antithymocyte globulin in matched sibling donor peripheral blood stem cell transplantation for hematologic malignancies
por: Dou, Liping, et al.
Publicado: (2021)

Less Graft-Versus-Host Disease after Rabbit Antithymocyte Globulin Conditioning in Unrelated Bone Marrow Transplantation for Leukemia and Myelodysplasia: Comparison with Matched Related Bone Marrow Transplantation
por: Atta, Elias Hallack, et al.
Publicado: (2014)

A Randomized 2×2 Factorial Trial, Part 1: Single-Dose Rabbit Antithymocyte Globulin Induction May Improve Renal Transplantation Outcomes
por: Stevens, R. Brian, et al.
Publicado: (2015)

Two dose levels of rabbit antithymocyte globulin as graft-versus-host disease prophylaxis in haploidentical stem cell transplantation: a multicenter randomized study
por: Lin, Ren, et al.
Publicado: (2019)

A Proposal for Early Dosing Regimens in Heart Transplant Patients Receiving Thymoglobulin and Calcineurin Inhibition
por: Barten, Markus J., et al.
Publicado: (2016)

High‐dose post‐transplant cyclophosphamide impairs γδ T‐cell reconstitution after haploidentical haematopoietic stem cell transplantation using low‐dose antithymocyte globulin and peripheral blood stem cell graft
por: Stocker, Nicolas, et al.
Publicado: (2020)

A comparison of post-transplantation cyclophosphamide versus antithymocyte-globulin in patients with hematological malignancies undergoing HLA-matched unrelated donor transplantation
por: Lee, Myung-Won, et al.
Publicado: (2020)

Burden of cytomegalovirus reactivation post kidney transplant with antithymocyte globulin use in Thailand: A retrospective cohort study
por: Chitasombat, Maria N., et al.
Publicado: (2018)

PB2188: APPLICATION PROSPECT OF LOW DOSE PORCINE ANTITHYMOCYTE GLOBULIN IN HLA MATCHED SIBLING DONOR TRANSPLANTATION
por: chen, X., et al.
Publicado: (2022)

Clinical Correlates and Outcomes of Dual Basiliximab and Antithymocyte Globulin Induction in Kidney Transplant Recipients: A National Study
por: Lam, Ngan N., et al.
Publicado: (2021)

The comparative efficacy and safety of basiliximab and antithymocyte globulin in deceased donor kidney transplantation: a multicenter cohort study
por: Hong, Su Yeon, et al.
Publicado: (2023)

Colonic EBV-Associated Lymphoproliferative Disorder in a Patient Treated with Rabbit Antithymocyte Globulin for Aplastic Anemia
por: Sugimoto-Sekiguchi, Hiroko, et al.
Publicado: (2012)

Graves disease following rabbit antithymocyte globulin treatment of severe aplastic anemia in a Korean child
por: Choi, In Su, et al.
Publicado: (2015)

Post-transplant cyclophosphamide versus antithymocyte globulin in patients with acute myeloid leukemia in first complete remission undergoing allogeneic stem cell transplantation from 10/10 HLA-matched unrelated donors
por: Brissot, Eolia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4bf30pmjbis54ebnbqn88tbs06